Cost of respiratory syncytial virus-associated acute lower respiratory infection management in young children at the regional and global level: a systematic review and …
S Zhang, LZ Akmar, F Bailey, BA Rath… - The Journal of …, 2020 - academic.oup.com
Background Respiratory syncytial virus (RSV) is a major cause of acute lower respiratory
infection (ALRI) in young children aged< 5 years. Methods We aimed to identify the global …
infection (ALRI) in young children aged< 5 years. Methods We aimed to identify the global …
Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis
SL Ralston, AS Lieberthal, HC Meissner… - …, 2014 - publications.aap.org
This guideline is a revision of the clinical practice guideline,“Diagnosis and Management of
Bronchiolitis,” published by the American Academy of Pediatrics in 2006. The guideline …
Bronchiolitis,” published by the American Academy of Pediatrics in 2006. The guideline …
Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children
T Andabaka, JW Nickerson… - … ‐Based Child Health …, 2013 - Wiley Online Library
Background Respiratory syncytial virus (RSV) is one of the most important viral pathogens
causing acute respiratory infections, resulting in about 3.4 million hospitalisations annually …
causing acute respiratory infections, resulting in about 3.4 million hospitalisations annually …
Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection
Committee on Infectious Diseases and Bronchiolitis … - …, 2014 - publications.aap.org
Guidance from the American Academy of Pediatrics (AAP) for the use of palivizumab
prophylaxis against respiratory syncytial virus (RSV) was first published in a policy statement …
prophylaxis against respiratory syncytial virus (RSV) was first published in a policy statement …
Palivizumab prophylaxis in infants and young children at increased risk of hospitalization for respiratory syncytial virus infection
MT Caserta, ST O'Leary, FM Munoz, SL Ralston - Pediatrics, 2023 - publications.aap.org
Guidance from the American Academy of Pediatrics (AAP) for the use of palivizumab
prophylaxis against respiratory syncytial virus (RSV) was first published in a policy statement …
prophylaxis against respiratory syncytial virus (RSV) was first published in a policy statement …
Orally efficacious broad-spectrum ribonucleoside analog inhibitor of influenza and respiratory syncytial viruses
JJ Yoon, M Toots, S Lee, ME Lee… - Antimicrobial agents …, 2018 - Am Soc Microbiol
Morbidity and mortality resulting from influenza-like disease are a threat, especially for older
adults. To improve case management, next-generation broad-spectrum antiviral …
adults. To improve case management, next-generation broad-spectrum antiviral …
Cost-effectiveness of palivizumab for respiratory syncytial virus: a systematic review
S Mac, A Sumner, S Duchesne-Belanger, R Stirling… - …, 2019 - publications.aap.org
OBJECTIVE: To systematically review the cost-effectiveness of palivizumab prophylaxis
compared with no prophylaxis in infants< 24 months of age. DATA SOURCES: Medline …
compared with no prophylaxis in infants< 24 months of age. DATA SOURCES: Medline …
Contribution of cytokines to tissue damage during human respiratory syncytial virus infection
The human respiratory syncytial virus (hRSV) remains one of the leading pathogens causing
acute respiratory tract infections (ARTIs) in children younger than 2 years old, worldwide …
acute respiratory tract infections (ARTIs) in children younger than 2 years old, worldwide …
Measles virus fusion protein: structure, function and inhibition
P Plattet, L Alves, M Herren, HC Aguilar - Viruses, 2016 - mdpi.com
Measles virus (MeV), a highly contagious member of the Paramyxoviridae family, causes
measles in humans. The Paramyxoviridae family of negative single-stranded enveloped …
measles in humans. The Paramyxoviridae family of negative single-stranded enveloped …
Social, economic, and health impact of the respiratory syncytial virus: a systematic search
Background Bronchiolitis caused by the respiratory syncytial virus (RSV) and its related
complications are common in infants born prematurely, with severe congenital heart …
complications are common in infants born prematurely, with severe congenital heart …